MyFinsight
Home
About
Contact
skye: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, SKYE has $41,324,289 in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Dollar
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
41,324,289
52,160,911
Total stockholders equity
32,836,185
43,676,709
Total liabilities and stockholders equity
41,324,289
52,160,911
Unit: Dollar
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Other current assets
$900,175
Prepaid expenses
$3,712,311
Short-term investments
$16,871,229
Cash and cash
equivalents
$18,441,079
Other assets
$53,910
Operating lease
right-of-use asset
$311,620
Property and equipment,
net
$1,033,965
Total current assets
$39,924,794
Total assets
$41,324,289
Total liabilities and
stockholders equity
$41,324,289
Total stockholders
equity
$32,836,185
Total liabilities
$8,488,104
Accumulated deficit
-$172,432,523
Additional
paid-in-capital
$205,237,719
Operating lease
liability, net of current...
$120,207
Total current
liabilities
$8,367,897
Common stock, 0.001 par
value 100,000,000...
$30,989
Operating lease
liability, current portion
$201,638
Estimate for accrued
legal contingencies...
$2,054,357
Other current
liabilities
$2,366,123
Accrued payroll
liabilities
$920,774
Accounts payable
$2,825,005
Subscribe for Financial Insights
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)